TSX/NYSE/PSE: MFC SEHK:945
WATERLOO, ON, March 16, 2015 /CNW/ - Manulife has appointed Dr. Laureen
Rance to the new role of Director of Pharmaceutical Relations. This
appointment is part of Manulife's pharmacy benefits strategy that will tackle the significant challenges related to the cost and accessibility of prescription drugs.
In combination with customer services, such as the Specialty Drug Care
program, an expanded authorization program, home delivery options and
more, Manulife is providing forward thinking solutions to ensure benefit plans are sustainable now and in the future.
"Without an action plan, the increasing prevalence of high-cost specialty drugs will impact the sustainability of private drug
plans," said Lisa Callaghan, Assistant Vice-President, Group Benefits Product at
Manulife. "Led by Dr. Rance, Manulife will work with pharmaceutical manufacturers to help
millions of Canadians through their employer sponsored benefit plans access valuable and innovative drugs, with the right support, at a
Dr. Laureen Rance (BScPharm, PharmD, MSc) has more than twenty years of experience working in health care,
beginning as a staff pharmacist in both retail and hospital settings.
After completing her Doctor of Pharmacy from the University of Toronto,
she transitioned to the pharmaceutical industry. She worked as a
reimbursement strategist with a focus on health economics and outcomes
research supporting numerous therapeutic categories with resulting
She went on to receive her Master of Science in Clinical Epidemiology
from the University of Toronto and transitioned her career to work in
pharmacy benefits management focused on evidence informed programs and
services. She is now rounding out her private payer experience with
"My extensive background working with varied pharmaceutical stakeholders
will enable me to work with the manufacturers," said Dr. Rance.
"Together we will find effective ways to continue to provide Manulife
customers with affordable access to medication and quality care."
Manulife is a leading Canada-based financial services group with
principal operations in Asia, Canada and the United States. We operate
as John Hancock in the U.S. and as Manulife in other parts of the
world. We provide strong, reliable, trustworthy and forward-thinking
solutions for our customers' significant financial decisions. Our
international network of employees, agents and distribution partners
offers financial protection and wealth management products and services
to millions of clients. We also provide asset management services to
institutional customers. Assets under management by Manulife and its
subsidiaries were approximately C$691 billion (US$596 billion) as at
December 31, 2014.
Manulife Financial Corporation trades as 'MFC' on the TSX, NYSE and PSE,
and under '945' on the SEHK. Manulife can be found on the Internet at manulife.com
SOURCE Manulife Financial Corporation
Image with caption: "Dr. Laureen Rance, Director Pharmaceutical Relations, Manulife (CNW Group/Manulife Financial Corporation)". Image available at: https://photos.newswire.ca/images/download/20150316_C9946_PHOTO_EN_43407.jpg
For further information: